Reinhold Vieth

Q: What Schools Are Affiliated With Reinhold Vieth

Reinhold Vieth is affiliated with the following schools: University of Calgary, University of British Columbia, University of Toronto

Reinhold Vieth's AcademicInfluence.com Rankings

Reinhold Vieth

Philosophy

#7380

World Rank

#10586

Historical Rank

Logic

#4435

World Rank

#5726

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Reinhold Vieth's Degrees

Masters Molecular Biology University of British Columbia

Why Is Reinhold Vieth Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Reinhold Vieth's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Estimates of optimal vitamin D status (2005) (1942)
Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. (1999) (1528)
Epidemic influenza and vitamin D (2006) (1001)
Risk assessment for vitamin D. (2007) (896)
The urgent need to recommend an intake of vitamin D that is effective. (2007) (727)
Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. (1998) (661)
Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. (2001) (646)
Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis (2012) (609)
The case against ergocalciferol (vitamin D2) as a vitamin supplement. (2006) (528)
Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. (2003) (436)
Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial. (2006) (369)
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis (2010) (323)
Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults (2004) (319)
Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it (2001) (303)
Association of Vitamin D With Insulin Resistance and β-Cell Dysfunction in Subjects at Risk for Type 2 Diabetes (2010) (295)
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study (2011) (288)
Vitamin D Toxicity, Policy, and Science (2007) (249)
What is the optimal vitamin D status for health? (2006) (248)
Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis23 (2008) (248)
13th Workshop consensus for vitamin D nutritional guidelines (2007) (246)
Safety of vitamin D3 in adults with multiple sclerosis. (2007) (245)
Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients (2004) (241)
Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper (2018) (234)
A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. (2006) (227)
Vitamin K Supplementation in Postmenopausal Women with Osteopenia (ECKO Trial): A Randomized Controlled Trial (2008) (220)
Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. (2008) (215)
An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. (2009) (206)
Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. (2009) (201)
Why the minimum desirable serum 25-hydroxyvitamin D level should be 75 nmol/L (30 ng/ml). (2011) (199)
Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. (2001) (196)
Vitamin D and seasonal fluctuations of gadolinium‐enhancing magnetic resonance imaging lesions in multiple sclerosis (2000) (191)
Evidence-based criteria in the nutritional context. (2010) (183)
Vitamin D and Reduced Risk of Breast Cancer: A Population-Based Case-Control Study (2007) (182)
A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations (1999) (175)
Longitudinal Evaluation of Vitamin D Status in Healthy Subjects from Southern Italy: Seasonal and Gender Differences (2001) (174)
The mechanisms of vitamin D toxicity. (1990) (171)
Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children. (2008) (149)
Supplemental Vitamins and Minerals for CVD Prevention and Treatment. (2018) (148)
The ratio of serum 24,25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 is predictive of 25-hydroxyvitamin D3 response to vitamin D3 supplementation (2011) (145)
Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards. (2006) (139)
Low wintertime vitamin D levels in a sample of healthy young adults of diverse ancestry living in the Toronto area: associations with vitamin D intake and skin pigmentation (2008) (131)
14th Vitamin D Workshop consensus on vitamin D nutritional guidelines (2010) (126)
Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. (2014) (126)
Sun exposure questionnaire predicts circulating 25-hydroxyvitamin D concentrations in Caucasian hospital workers in southern Italy (2010) (122)
Seasonal Prevalence of Vitamin D Deficiency in Institutionalized Older Adults (1997) (120)
Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. (2002) (118)
Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components. (2011) (118)
Bone mineral density by age, gender, pubertal stages, and socioeconomic status in healthy Lebanese children and adolescents. (2004) (117)
Prospective Associations of Vitamin D With β-Cell Function and Glycemia (2011) (114)
Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial. (2015) (110)
How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. (2009) (108)
Evidence that vitamin D 3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D 2 1 – 3 (103)
Vitamin D: a growing perspective. (2008) (103)
CHAPTER 61 – The Pharmacology of Vitamin D, Including Fortification Strategies (2005) (102)
Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial (2011) (100)
Proceedings of the Rank Forum on Vitamin D (2010) (96)
Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women. (2010) (96)
Vitamin D3 fortification and quantification in processed dairy products (2007) (95)
Comparison of vitamin D 2 and vitamin D 3 supplementation in raising serum 25-hydroxyvitamin D status : a systematic review and meta-analysis 1 – 3 (2012) (94)
The bioavailability of vitamin D from fortified cheeses and supplements is equivalent in adults. (2008) (93)
Long-term effects of giving nursing home residents bread fortified with 125 microg (5000 IU) vitamin D(3) per daily serving. (2009) (91)
Tumor Suppressor microRNAs, miR-100 and -125b, Are Regulated by 1,25-dihydroxyvitamin D in Primary Prostate Cells and in Patient Tissue (2013) (90)
Sex differences in the effect of body-composition variables on bone mass in healthy children and adolescents. (2004) (88)
Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis. (2011) (85)
Association between serum 25‐hydroxyvitamin D in early pregnancy and risk of gestational diabetes mellitus (2012) (85)
Association between total serum calcium and the A986S polymorphism of the calcium-sensing receptor gene. (2001) (81)
Pilot Study: Potential Role of Vitamin D (Cholecalciferol) in Patients With PSA Relapse After Definitive Therapy (2005) (78)
Randomized trial of daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon β-1a (2019) (78)
Serum 25-hydroxyvitamin D concentrations fluctuate seasonally in young adults of diverse ancestry living in Toronto. (2010) (77)
Relationship between vitamin D during perinatal development and health. (2010) (77)
Randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and ki67 labeling in prostate cancer patients. (2013) (76)
The development and evaluation of a food frequency questionnaire used in assessing vitamin D intake in a sample of healthy young Canadian adults of diverse ancestry. (2009) (75)
A phase 2 trial exploring the effects of high‐dose (10,000 IU/day) vitamin D3 in breast cancer patients with bone metastases (2010) (74)
Serum 25-hydroxyvitamin D is a predictor of serum 1,25-dihydroxyvitamin D in overweight and obese patients. (2011) (73)
Kinetic behavior of 25-hydroxyvitamin D-1-hydroxylase and -24-hydroxylase in rat kidney mitochondria. (1979) (73)
Why “Vitamin D” is not a hormone, and not a synonym for 1,25-dihydroxy-vitamin D, its analogs or deltanoids (2004) (69)
Vitamin D poisoning by table sugar (2002) (67)
Prospective association of 25(OH)D with metabolic syndrome (2014) (66)
A phase III international randomised trial comparing single with multiple fractions for re-irradiation of painful bone metastases: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC 20. (2006) (64)
Association of vitamin D with insulin resistance and β-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 2010;33:1379―1381 (2011) (64)
Vitamin D association with estradiol and progesterone in young women (2010) (62)
The role of vitamin D in the prevention of osteoporosis (2005) (61)
Vitamin D and cancer mini-symposium: the risk of additional vitamin D. (2009) (60)
Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice. (2013) (58)
Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): A double‐blind, randomized, placebo‐controlled clinical trial (2017) (58)
Cod Liver Oil, Vitamin A Toxicity, Frequent Respiratory Infections, and the Vitamin D Deficiency Epidemic (2008) (57)
Vitamin D from dietary intake and sunlight exposure and the risk of hormone-receptor-defined breast cancer. (2008) (57)
Vitamin D: A Growing Perspective (2008) (57)
Vitamin D3 fortification, quantification, and long-term stability in Cheddar and low-fat cheeses. (2008) (56)
The genetic influence on bone susceptibility to fluoride. (2006) (55)
Role of 25-hydroxyvitamin D3 dose in determining rat 1,25-dihydroxyvitamin D3 production. (1990) (54)
Simple method for determining specific binding capacity of vitamin D-binding protein and its use to calculate the concentration of "free" 1,25-dihydroxyvitamin D. (1994) (48)
Epidemic influenza and vitamin (2006) (47)
Randomized, double-blinded, placebo-controlled, trial of risedronate for the prevention of bone mineral density loss in nonmetastatic prostate cancer patients receiving radiation therapy plus androgen deprivation therapy. (2013) (47)
Low dietary calcium reduces 25-hydroxycholecalciferol in plasma of rats. (1987) (44)
Problems with direct 25-hydroxyvitamin D assays, and the target amount of vitamin D nutrition desirable for patients with osteoporosis. (2000) (43)
Vitamin D insufficiency: no recommended dietary allowance exists for this nutrient. (2002) (43)
Alleles of the Estrogen Receptor α‐Gene and an Estrogen Receptor Cotranscriptional Activator Gene, Amplified in Breast Cancer‐1 (AIB1), Are Associated with Quantitative Calcaneal Ultrasound (2000) (41)
The effect of fluoride on bone histology in postmenopausal osteoporosis depends on adequate fluoride absorption and retention (1988) (41)
Vitamin D supplementation: cholecalciferol, calcifediol, and calcitriol (2020) (40)
Vitamin D Round Table (2004) (39)
No Association Between 25-Hydroxyvitamin D and Mammographic Density (2006) (39)
Vitamin D insufficiency and musculoskeletal health in children and adolescents (2007) (38)
Enzyme kinetics hypothesis to explain the U‐shaped risk curve for prostate cancer vs. 25‐hydroxyvitamin D in nordic countries (2004) (38)
There is no lower threshold level for parathyroid hormone as 25-hydroxyvitamin D concentrations increase (2005) (38)
Association of Vitamin D–Related Information from a Telephone Interview with 25-Hydroxyvitamin D (2008) (37)
Improved cholecalciferol nutrition in rats is noncalcemic, suppresses parathyroid hormone and increases responsiveness to 1, 25-dihydroxycholecalciferol. (2000) (37)
Greater seasonal cycling of 25-hydroxyvitamin D is associated with increased parathyroid hormone and bone resorption (2014) (37)
Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model (2015) (35)
Implications for 25-Hydroxyvitamin D testing of public health policies about the benefits and risks of Vitamin D fortification and supplementation (2012) (33)
Vitamin D Nutrition and its Potential Health Beneéts for Bone, Cancer and Other Conditions (2001) (32)
Safety of vitamin D 3 in adults with multiple sclerosis 1 – 3 (2007) (31)
Fluoride treatment of postmenopausal osteoporosis: Age, renal function, and other clinical factors in the osteogenic response (1990) (31)
Difficulties with vitamin D nutrition research: objective targets of adequacy, and assays for 25-hydroxyvitamin D (2001) (31)
Vitamin D in congestive heart failure. (2006) (31)
Evaluation of a 1,25-dihydroxyvitamin D enzyme immunoassay. (2007) (30)
Extraction and measurement of pamidronate from bone samples using automated pre-column derivatization, high-performance liquid chromatography and fluorescence detection. (1996) (29)
Longitudinal study of vitamin D metabolites after long bone fracture (2013) (27)
Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment: JACC Focus Seminar. (2021) (27)
Vitamin D nutrient to treat TB begs the prevention question (2011) (26)
A comparison of automated methods for the quantitation of serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. (2007) (26)
Species differences in the binding kinetics of 25-hydroxyvitamin D3 to vitamin D binding protein. (1990) (26)
Relevance of vitamin D metabolite concentrations in supporting the diagnosis of primary hyperparathyroidism. (1991) (26)
Comparisons between oral and intraperitoneal 1,25-dihydroxyvitamin D3 therapy in children treated with peritoneal dialysis. (1994) (25)
Effect of high vegetable protein diets on urinary calcium loss in middle-aged men and women (2003) (25)
microRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma (2017) (25)
Fluoride‐induced fractures: Relation to osteogenic effect (1990) (25)
Effect of vitamin D replacement on hip structural geometry in adolescents: a randomized controlled trial. (2013) (24)
Self-prescribed high-dose vitamin D3: effects on biochemical parameters in two men (2008) (24)
Effects of Vitamin D on Bone and Natural Selection of Skin Color: How Much Vitamin D Nutrition are We Talking About? (2003) (24)
Efficacy and safety of vitamin D 3 intake exceeding the lowest observed adverse effect level 1 – 3 (24)
Solar ultraviolet-B radiation and vitamin D: a cross-sectional population-based study using data from the 2007 to 2009 Canadian Health Measures Survey (2012) (23)
The long‐term treatment of steroid osteoporosis with fluoride (1990) (23)
Determination of 1,25-dihydroxyvitamin D concentrations in human colon tissues and matched serum samples. (2012) (21)
Primary infantile hypomagnesaemia: outcome after 21 years and treatment with continuous nocturnal nasogastric magnesium infusion (2000) (20)
125I-RIA kit cannot distinguish vitamin D deficiency as well as a more specific assay for 25-hydroxyvitamin D. (1995) (19)
Three-year follow-up of serum 25-hydroxyvitamin D, parathyroid hormone, and bone mineral density in nursing home residents who had received 12 months of daily bread fortification with 125 μg of vitamin D3 (2013) (18)
Rise in Prostate-Specific Antigen in Men with Untreated Low-Grade Prostate Cancer Is Slower During Spring-Summer (2006) (17)
Renal osteodystrophy in children on CAPD: a prospective trial of 1-alpha-hydroxycholecalciferol therapy. (1988) (17)
The case against ergocalciferol (vitamin D 2 ) as a vitamin supplement 1,2 (2006) (17)
Regulation Of Sodium, Calcium And Vitamin D Metabolism In Dahl Rats On A High‐Salt/Low‐Potassium Diet: Genetic And Neural Influences (2000) (16)
25-Hydroxyvitamin D variability within-person due to diurnal rhythm and illness: a case report (2019) (16)
The Pharmacology of Vitamin D (2011) (16)
The IOM—Endocrine Society Controversy on Recommended Vitamin D Targets: In Support of the Endocrine Society Position (2018) (15)
Would prehistoric human 25-hydroxyvitamin D concentrations be beneficial, and how much vitamin D do we need to ensure desirable nutritional targets? (2001) (14)
25-Hydroxyvitamin D Metabolism in the Sheep Fetus and Lamb (1980) (14)
Individual participant data (IPD)-level meta-analysis of randomised controlled trials with vitamin D-fortified foods to estimate Dietary Reference Values for vitamin D (2020) (14)
Randomized Clinical Trial of Vitamin D 3 Doses on Prostatic Vitamin D Metabolite Levels and Ki 67 Labeling in Prostate Cancer Patients (2013) (14)
Unusually prolonged vitamin D intoxication after discontinuation of vitamin D: possible role of primary hyperparathyroidism (2008) (14)
Moderate vitamin D3 supplementation lowers serum 1,25-dihydroxy-vitamin D3 in rats (1995) (13)
Urinary calcium response to high dose vitamin D3 with calcium supplementation in patients with multiple sclerosis. (2011) (13)
A Randomized Double-Blind Placebo-Controlled Trial of the Effect of Vitamin D3 Supplementation on Breast Density in Premenopausal Women (2017) (12)
Inhibition of alkaline phosphatase by cysteine: implications for calcium pyrophosphate dihydrate crystal deposition disease. (2007) (12)
Tracer kinetics and actions of oral and intraperitoneal 1,25-dihydroxyvitamin D3 administration in rats. (1990) (11)
Effect of re-irradiation for painful bone metastases on urinary markers of osteoclast activity (NCIC CTG SC.20U). (2015) (11)
Estrogen dose required to maintain parathyroid hormone mediated bone gain in osteopenic ovariectomized rats is probably higher than in preventive treatment with estrogen. (1995) (10)
Change in urinary markers of osteoclast activity following palliative radiotherapy for bone metastases. (2009) (9)
Comment on Chel et al.: Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents (2008) (9)
Novel fluorescent compound (DDP) in calf, rabbit, and human articular cartilage and synovial fluid. (2002) (9)
Randomized window of opportunity trial evaluating high-dose vitamin D in breast cancer patients (2019) (8)
Teriparatide, osteoporosis, calcium, and vitamin D. (2005) (8)
A cartilage derived novel compound DDP (2,6-dimethyldifuro-8-pyrone): isolation, purification, and identification. (2002) (8)
Vitamin D efficacy and safety. (2011) (8)
cacy of vitamin D 3 as add-on therapy in patients with relapsing – remitting multiple sclerosis receiving subcutaneous interferon beta-1 a : A Phase II , multicenter , double-blind , randomized , placebo-controlled trial (2011) (7)
Bioavailability and Safety of Vitamin D3 from Pizza Baked with Fortified Mozzarella Cheese: A Randomized Controlled Trial. (2015) (7)
Vitamin D2 and vitamin D3 comparisons: fundamentally flawed study methodology. (2010) (7)
Weaker bones and white skin as adaptions to improve anthropological “fitness” for northern environments (2019) (7)
Pamidronate content and turnover in sternum, vertebral body, and iliac bones of dogs. (1997) (6)
Presystemic 24‐hydroxylation of oral 25‐hydroxyvitamin D3 in rats (1990) (6)
Toxicity of Vitamin D (2010) (6)
Comparison of self-reported lifetime sun exposure with two methods of cutaneous microtopography. (2006) (5)
Long-term effects of giving nursing home residents bread fortified with 125 l g ( 5000 IU ) vitamin D 3 per daily serving 1 – 4 (2009) (5)
Risk assessment for vitamin D 1,2 (2007) (5)
Experimentally observed vitamin D requirements are higher than extrapolated ones. (2009) (5)
Functional T436K SNP in DBP is a predictor of serum 25(OH)D: A replicate study in a young healthy adult population (2008) (5)
Bread as a Vehicle Vitamin D Fortification: Application to Nursing Home Residents (2013) (4)
Status and Pancreatic Cancer Risk in Male Smokers A Prospective Nested Case-Control Study of Vitamin D Updated (2006) (4)
Sunbeds with UVB radiation can produce physiological levels of serum 25-Hydroxyvitamin D in healthy volunteers (2017) (4)
Vitamin D in pregnant women (2002) (3)
Reply to J Hathcock and I Munro (2001) (3)
Lack of generalizable evidence of the superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis: comment on the article by Ringe et al. (2004) (3)
The future of "vitamin D", i.e. 25-hydroxyvitamin D, testing. (2013) (3)
Inaccuracies in relating 25-hydroxyvitamin D to ischemic heart disease. (2003) (3)
The Paleolithic Nutrition Model in Relation to Ultraviolet Light and Vitamin D. (2020) (3)
Misuse of terminology to imply that 1,25-dihydroxy-vitamin D is a nutrient: there is no evidence for an association between vitamin D and allergy. (2004) (3)
A Phase I/II Dose‐Escalation Trial of Vitamin D3 with Calcium Supplementation in Patients with Multiple Sclerosis (2008) (3)
Reply to FAJ Muskiet et al (2001) (3)
Neither human nor mouse is hypercalcaemic with 250 nmol/l 25-hydroxyvitamin D. (2019) (2)
Abstract LB-435: Double-blind randomized clinical trial of vitamin D3 showing effects on tissue calcitriol levels, gene expression and proliferation immunohistochemistry in prostate cancer (2012) (2)
Vitamin D metabolism in Mexican-Americans. (1990) (2)
Vitamin D nutrition does not cause peripheral artery disease. (2005) (2)
Vitamin D ingestion and changes to rat aorta. (2002) (2)
Basic Aspects of Vitamin D Nutrition (2010) (2)
Critique of Public Health Guidance for Vitamin D and Sun Exposure in the Context of Cancer and COVID-19 (2022) (1)
Vitamin D2v. vitamin D3 supplementation in raising 25OHD status: preliminary findings of a meta-analysis (2011) (1)
Mistakes in terminology cause false conclusions: Vitamin D does not increase the risk of dementia (2022) (1)
Re: Statistics in “clinical biochemistry” papers (1982) (1)
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 4th ed., C.A. Burtis, E.R. Ashwood, D.E. Bruns (Eds.). Elsevier Inc. (2006) (2006) (1)
Randomized controlled trial comparing the bioavailability of vitamin D3 from fortified Cheddar cheese, fortified low‐fat cheese, and supplement (2008) (1)
Higher bone resorption excretion in South Asian women vs. White Caucasians and increased bone loss with higher seasonal cycling of vitamin D: Results from the D-FINES cohort study. (2017) (1)
Pamidronate content and turnover in vertebral and iliac bones of dog (1995) (1)
in School Children Supplementation 3 Short- and Long-Term Safety of Weekly High-Dose Vitamin D (2008) (1)
WAS IT INAPPROPRIATE TO GIVE PATIENTS WITH OSTEOPOROSIS CALCITRIOL INSTEAD OF VITAMIN D? (2008) (1)
Proceedings of the Rank Forum on Vitamin (2010) (1)
Letter to Editor: Inaccuracies in relating 25-hydroxyvitamin D to ischemic heart disease (2002) (1)
Effect of Vitamin D Fortified Cheese on Oral Glucose Tolerance in Individuals Exhibiting Marginal Vitamin D Status and an Increased Risk for Developing Type 2 Diabetes: A Double‐Blind, Randomized Placebo‐Controlled Clinical Trial (2016) (1)
An Appraisal to Address Health Consequences of Vitamin D Deficiency With Food Fortification and Supplements: Time to Act! (2022) (1)
UVB-emitting cloth to prevent low serum 25-hydroxyvitamin D caused by clothing (2022) (0)
Nutrient Metabolism Improved Cholecalciferol Nutrition in Rats Is Noncalcemic , Suppresses Parathyroid Hormone and Increases Responsiveness to 1 , 25-Dihydroxycholecalciferol 1 (2000) (0)
Abstract of the international conference on progress in bone and mineral research Pathophysiology and clinical problemLow dose, cyclical parathyroid hormone and estrogen treatment of osteopenic ovariectomized adult rats (1995) (0)
Serum 25-Hydroxyvitamin D Concentrations Fluctuate Seasonally in Young Adults of Diverse Ancestry Living in Toronto 1 , 2 (2010) (0)
P135 HOW DOES VITAMIN D AFFECT BONE AND CARTILAGE IN A GUINEA PIG MODEL OF OSTEOARTHRITIS (2006) (0)
84 HOW DOES VITAMIN D AFFECT BONE AND CARTILAGE IN THE SPONTANEOUS GUINEA PIG MODEL OF OSTEOARTHRITIS (2007) (0)
Review for "Natural Vitamin D in Food: To What Degree Does 25-Hydroxyvitamin D Contribute to the Vitamin D Activity in Food?" (2020) (0)
Seasonal variation in vitamin D status in healthy young adults of different ancestry in the Toronto area (2009) (0)
Correction: Vitamin K Supplementation in Postmenopausal Women with Osteopenia (ECKO Trial): A Randomized Controlled Trial (2008) (0)
Letter to the editor (1990) (0)
Mo2018 Vitamin D Deficiency in Utero Through Adulthood Results in an Inflammation-Prone Colonic Gene Expression Profile in Healthy CD-1 Mice While IL-10 Knock-out Mice are Not Responsive (2012) (0)
Derives de difuropyrone (2000) (0)
The A986S polymorphism of the calcium-sensing receptor (CASR) gene is a significant contributor to inter-individual variability of serum calcium (2000) (0)
URINARY CALCIUM AND SERUM l,25(OH)2D CORRELATE IN KIDNEY STONE PATIENTS (1991) (0)
ASBMR 25th Annual Meeting SU001–SU482 (2003) (0)
Evaluation of automated methods for quantifying serum 25‐hydroxyvitamin D (2008) (0)
ORIGINAL COMMUNICATION Effect of high vegetable protein diets on urinary calcium loss in middle-aged men and women (2003) (0)
Correction to: Weaker bones and white skin as adaptions to improve anthropological “fitness” for northern environments (2020) (0)
Technology and Pregnancy (2014) (0)
Vitamin D supplementation. (1993) (0)
Evaluation of the Roche vitamin D total {25-hydroxyvitamin D2 and D3; (25(OH)D)} immunoassay (2012) (0)
Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety 1,2 (1999) (0)
What is the Optimal Amount of Vitamin D for Osteoporosis (2004) (0)
Hypercalcemia and a “no observed adverse effect level” intake of vitamin D (2019) (0)
Analytical evaluation of the IDS-iSYS 25-Hydroxy vitamin D (25(OH)D) immunoassay (2011) (0)
Vitamin D‐Casein fortification of cheese and its bioavailability (2012) (0)
Evaluation of a new 25-hydroxyvitamin D 125I ria kit (1994) (0)
Greater seasonal cycling of 25-hydroxyvitamin D is 1 associated with increased parathyroid hormone and bone 2 resorption 3 4 (0)
Serum 25‐hydroxyvitamin D as a determinant of multiple sclerosis outcome following a pediatric demyelinating event (2009) (0)
Best Practice & Research Clinical Endocrinology & Metabolism (2011) (0)
Serum 25‐Hydroxyvitamin‐D and Prostate Cancer U‐Shaped Risk Curves‐Does Latitude Play A Role? A Meta‐Analysis of Case‐Control Studies (2015) (0)
Evidence of in vivo Immune Modulation with Vitamin D3 and Calcium Supplementation in Multiple Sclerosis (2010) (0)
Unique Features of the Enzyme Kinetics for the Vitamin D System, and the Implications for Cancer Prevention and Therapeutics (2011) (0)
The association of vitamin D related variables with 25-hydroxyvitamin D. (2006) (0)
High‐dose oral vitamin D3 administration increases serum and prostate levels of vitamin D metabolites safely in prostate cancer patients (2012) (0)
Vitamin D binding protein (DBP) polymorphisms predict vitamin D metabolism but not bone mineral density in a cohort of healthy young women (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Reinhold Vieth?

Reinhold Vieth is affiliated with the following schools: